Mainstream

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Post ContentcaprRead More

You might also be interested in reading Ubisoft cools off on NFTs and blockchain, says it’s in ‘research mode’.

May 14, 2025
In Mainstream